SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-21-000062
Filing Date
2021-05-04
Accepted
2021-05-04 08:15:30
Documents
16
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-20210504.htm   iXBRL 8-K 47584
2 EX-99 pfe-04042021xex99.htm EX-99 991105
8 pfizerlogo1.jpg GRAPHIC 38679
  Complete submission text file 0000078003-21-000062.txt   1351127

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20210504.xsd EX-101.SCH 3210
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20210504_cal.xml EX-101.CAL 717
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20210504_def.xml EX-101.DEF 16025
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20210504_lab.xml EX-101.LAB 31785
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20210504_pre.xml EX-101.PRE 16704
9 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20210504_htm.xml XML 16096
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 21886083
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences